Src cDNA Expression Kit (wild type)...
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Lipofectin Reagent is the reagent of choice for some cell lines; cells of endothelial derivation transfect well with Lipofectin Reagent....
Request Info...
Biology Products:... DNA into the space of a typical chromosome, a ... material it contains. , "It is like compacting your ... Emeritus in Physics at the University of Chicago. , ... showing that these and related organisms may have evolved ...
... the Tahitian vanilla orchid, whose cured fruit is the source ... has long eluded botanists. Known by the scientific name ... in cultivation; natural, wild populations of the orchid have never ... led by Pesach Lubinsky, a postdoctoral researcher with Norman ...
... (August 21, 2008) The leading figures ... most exciting breakthroughs in this revolutionary field of research ... annual Translational Stem Cell Research Conference, October 14-15 at ... focus on the dramatic advancements researchers are making in ...
Other Biology News:Exploding chromosomes fuel research about evolution of genetic storage 2Exploding chromosomes fuel research about evolution of genetic storage 3Tahitian vanilla originated in Maya forests, says UC Riverside botanist 2Tahitian vanilla originated in Maya forests, says UC Riverside botanist 3New York Stem Cell Foundation announces third annual Translational Stem Cell Research Conference 2New York Stem Cell Foundation announces third annual Translational Stem Cell Research Conference 3(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) ... new, three-year master services agreement with a ... services that serve patients in approximately 100 ... the sole provider for translation of the ... training, human resources, legal, and corporate communications ...
(Date:12/11/2009)... Dec. 11 EntreMed, Inc. (Nasdaq: ... million in royalty revenue from sales of Thalomid® ... revenue of $3.3 million. In addition, the ... projected revenue for fiscal 2009. The difference ... quarter will be reflected in the fourth quarter ...
(Date:12/11/2009)... Corporation announced today the enrollment and dosing at the ... the first patient in the ACE ( AC ... 2 pivotal trial in patients with relapsed or refractory ... orally available, potent and highly selective small molecule that ... inhibitor. The ACE study is designed to be ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Biology NavigationMedical Navigation